I CFD sono strumenti complessi e presentano un alto rischio di perdere soldi rapidamente a causa della leva finanziaria. Il 74% dei conti di clienti al dettaglio perde denaro facendo trading con i CFD con questo fornitore. Devi verificare se comprendi pienamente come funzionano i CFD e se puoi permetterti di correre il rischio elevato di perdere i tuoi soldi.

Close

Fai trading su Gilead GILD

Vendi
 Acquista

Grafico live di Gilead

5m 15m 30m 1h 4h 1d 1w

Fondamentali dello strumento

Weekly Search
Weekly
Daily
Data Chiudi Variazione variazione % Apertura Massimo Minimo

Le ultime notizie

Closing 2024
2024 Dec 26, 17:00

La prossima settimana:Chiusura del 2024 e primi dati economici del 2025

Forex Indici
UK GDP
Dyogenes Diniz 2024 Dec 19, 16:00

La prossima settimana: Ultima settimana del 2024 sui mercati finanziari

Forex Indici
US interest rate and Europe inflation to guide market direction
Markets.com Support Team 2024 Dec 13, 22:00

La prossima settimana: I tassi di interesse USA e l’inflazione in Europa determineranno la direzione dei mercati

Forex Indici
Dyogenes Diniz 2024 Dec 05, 16:00

La prossima settimana: L’inflazione e i tassi di interesse condizioneranno i mercati questa settimana

Forex Indici
US Employment Rate
Markets.com Support Team 2024 Nov 28, 17:00

La prossima settimana: L’occupazione USA probabilmente guiderà il sentiment sul mercato questa settimana.

Forex Indici
Eurozone inflation
Markets.com Support Team 2024 Nov 23, 16:00

La prossima settimana: I dati sull’inflazione nell’area euro probabilmente confermeranno il taglio di dicembre dei tassi della BCE

Forex Indici
Nvidia Blackwell AI Chips
Markets.com Support Team 2024 Nov 14, 16:00

L’importante rally dei titoli del tech in parte dipenderà dalle trimestrali di Nvidia che verranno pubblicate mercoledì.

Forex Indici
Markets.com Support Team 2024 Nov 07, 16:00

La prossima settimana: Trump trade, dati sull’inflazione e trimestrali di Disney

Forex Indici

Informazioni

Spread

0.63

Spread (%)

0.6240 %

Leva

1:5

Interesse overnight acquisto

-0.0597 %

Interesse overnight vendita

-0.0292 %

Valuta

USD

Orari di trading

Markets closed

Venerdì

13:31 - 19:59

Lunedì

13:31-19:59

Martedì

13:31-19:59

Mercoledì

13:31-19:59

Giovedi

13:31-19:59

Analisi e statistiche

Apertura

---

Chiusura precedente

---

Massimo/Minimo di 52 settimane

--- – ---

Capitalizzazione di mercato

129188265984

Azioni in circolazione

1246630016

Data delle trimestrali (prossima)

2013-01-28

Rendimento da dividendo

2025-03-28

Data ex dividendo

2025-03-14

Tasso di dividendo annuale a termine

3.16

Rendimento del dividendo annuale a termine

0.0295

EPS

0.38

Scopri di più su questo strumento

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Strumenti correlati

Asset
Vendi
Acquista
variazione %

Fai trading ora

Fai trading ora

Fai trading ora

Fai trading ora
Strumenti correlati
Trustpilot
RequestMessages4TimelineExceptionsViews0RouteQueries0Models0MailsGateSession
SettingsRequest history38.1.18PHP Version40.71msRequest Duration2MBMemory UsageGET params
status
200 OK
full_url
https://web-qa.staging.markets.com/params
controller_action
App\Http\Controllers\TrackingParams@fetch
Theme
Open Button Position
Hide Empty Tabs
Autoshow
Reset to defaults
status
200 OK
full_url
https://web-qa.staging.markets.com/params
action_name
controller_action
App\Http\Controllers\TrackingParams@fetch
uri
GET params
controller
App\Http\Controllers\TrackingParams@fetch
file
app/Http/Controllers/TrackingParams.php:11-31
middleware
web
duration
40.91ms
peak_memory
4MB
response
application/json
request_format
html
request_query
[]
request_request
[]
request_headers
  0 of 0   
array:14 [▼
  "cookie" => array:1 [▶
    0 => "mktloc=eyJpdiI6Ijh2RUhwcXJGS2d5MXQyQTJMR1BTbmc9PSIsInZhbHVlIjoiT1Vsd0ErVjFRbUV3R1ozMlN3TU1yRXVjdnFJVkp0Z2V0cmppYUtobWViODlIbVo3a1lkTUcvNjlPcEJPTW9yYSIsIm1hYyI6Ijc0MzhiZmU1MTAwOTQxNzYyMjYwZGU3MTg2YjFhZDk5NGJkZTczODRlNWQwMTJkMDI4OWQwOTExNzA2OTVkMjIiLCJ0YWciOiIifQ%3D%3D; mktv4_ip_override=my; firstURL=https://web-qa.staging.markets.com/ta/instrument/quanta/; lastURL=https://web-qa.staging.markets.com/ta/instrument/quanta/; intent_group=%252Fmy%252Finstrument%252Fpaypal%252F; intent_instrument=paypal; XSRF-TOKEN=eyJpdiI6IjVPeWFYYllrNGxzWWxubllCcndvR1E9PSIsInZhbHVlIjoidU8wOVNQamppcW5LYUVYSEpEdTZKMkxsMnVQL3VxLzhPRHBKUmY1ampWQlFuYXFmc0xBRkdRSEFIRW1VL0dZeGM3RXYvOFI5VmFrRDd0cjNaNUdUbHhQQW0vTkxtcFFhSG9ZRFROQmxSbVA4dG9XMi9NWks4OVd4VnlOMmI1WTIiLCJtYWMiOiI0OGY5NWQ2NjBiYmFmMzk2ODI4NjdjYTVjZGE5MzE0OGJmYWQ0NzZkNjZmODJhZTZhZTJiZGYxZWEwZDVhNDY4IiwidGFnIjoiIn0%3D; laravel_session=eyJpdiI6IkJmbEVMZEE2MHk0VmpEOURUaWVsbXc9PSIsInZhbHVlIjoielRJU0c5SkEyM2RrdS9SemtLaytUK0czVnI5eWp1MXJMOW16Wk9XRk0yZmY1QmVzTXZaNmdZdWJONWhSSXYzeEZmRFh0M0srd3BOeTA3akJYOFNVM0NHTTNtTzVvS3hSMW16REVuaVFZbnVuUU11WmVHcTUvdk03Z2xQN2grS2wiLCJtYWMiOiIzMDY3Njc5MzM1NTkwZjMxMzA5MGQ0ZjljMjAyMjBjYjZiZjVkODkzMmViODJlNTRlMzIxY2FmNmI3ZWE4ZTYxIiwidGFnIjoiIn0%3D ◀mktloc=eyJpdiI6Ijh2RUhwcXJGS2d5MXQyQTJMR1BTbmc9PSIsInZhbHVlIjoiT1Vsd0ErVjFRbUV3R1ozMlN3TU1yRXVjdnFJVkp0Z2V0cmppYUtobWViODlIbVo3a1lkTUcvNjlPcEJPTW9yYSIsIm1hYyI6I ▶"
  ]
  "accept-encoding" => array:1 [▶
    0 => "gzip, deflate, br, zstd"
  ]
  "sec-fetch-dest" => array:1 [▶
    0 => "empty"
  ]
  "sec-fetch-mode" => array:1 [▶
    0 => "cors"
  ]
  "sec-fetch-site" => array:1 [▶
    0 => "same-origin"
  ]
  "accept" => array:1 [▶
    0 => "*/*"
  ]
  "sec-ch-ua-mobile" => array:1 [▶
    0 => "?0"
  ]
  "sec-ch-ua" => array:1 [▶
    0 => ""HeadlessChrome";v="129", "Not=A?Brand";v="8", "Chromium";v="129""
  ]
  "user-agent" => array:1 [▶
    0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)"
  ]
  "sec-ch-ua-platform" => array:1 [▶
    0 => ""Windows""
  ]
  "cache-control" => array:1 [▶
    0 => "no-cache"
  ]
  "pragma" => array:1 [▶
    0 => "no-cache"
  ]
  "connection" => array:1 [▶
    0 => "keep-alive"
  ]
  "host" => array:1 [▶
    0 => "web-qa.staging.markets.com"
  ]
]
request_cookies
  0 of 0   
array:8 [▼
  "mktloc" => "us,us"
  "mktv4_ip_override" => null
  "firstURL" => null
  "lastURL" => null
  "intent_group" => null
  "intent_instrument" => null
  "XSRF-TOKEN" => "FdQ11yNVdknSb0sJIboVPH0ECDTgtLRfQlCDFhGT"
  "laravel_session" => "D8X1dEpgYHFLyGSv4XB6iezDzU01e5Q4tM9x0Wcq"
]
response_headers
  0 of 0   
array:3 [▼
  "cache-control" => array:1 [▶
    0 => "no-cache, private"
  ]
  "date" => array:1 [▶
    0 => "Sat, 12 Apr 2025 23:05:29 GMT"
  ]
  "content-type" => array:1 [▶
    0 => "application/json"
  ]
]
session_attributes
  0 of 0   
array:4 [▼
  "_token" => "FdQ11yNVdknSb0sJIboVPH0ECDTgtLRfQlCDFhGT"
  "PHPDEBUGBAR_STACK_DATA" => []
  "_previous" => array:1 [▶
    "url" => "https://web-qa.staging.markets.com/csrf"
  ]
  "_flash" => array:2 [▶
    "old" => []
    "new" => []
  ]
]
    • Booting (21.93ms)time
    • Application (18.77ms)time
    • Routing (491μs)
    • 1 x Booting (53.86%)
      21.93ms
      1 x Application (46.11%)
      18.77ms
      1 x Routing (1.21%)
      491μs
      0 templates were rendered
        uri
        GET params
        middleware
        web
        controller
        App\Http\Controllers\TrackingParams@fetch
        file
        app/Http/Controllers/TrackingParams.php:11-31
        0 statements were executed0μs
              _token
              FdQ11yNVdknSb0sJIboVPH0ECDTgtLRfQlCDFhGT
              PHPDEBUGBAR_STACK_DATA
              []
              _previous
              array:1 [ "url" => "https://web-qa.staging.markets.com/csrf" ]
              _flash
              array:2 [ "old" => [] "new" => [] ]
              ClearShow all
              Date ↕MethodURLData
              #12025-04-12 23:05:27GET/it/instrument/gilead/467
              #22025-04-12 23:05:28GET/csrf/ (ajax)
              #32025-04-12 23:05:29GET/params/ (ajax)